Pricing Log in Create free account

Coya Therapeutics, Inc. (COYA) vs MediciNova, Inc. (MNOV)

Coya Therapeutics, Inc. and MediciNova, Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and MediciNova, Inc. are of similar size ($71.4M and $65.9M). Coya Therapeutics, Inc. grew revenue faster over the last twelve months: 108.4% against −82.2%. Coya Therapeutics, Inc. has the higher net margin (−270.2% vs −1,168.3%) and the lower return on invested capital (−15,230.9% vs −62.5%). Across the 16 metrics below, Coya Therapeutics, Inc. leads on 10 and MediciNova, Inc. on 6.

Valuation

Metric COYA MNOV Biotechnology median
P/E n/m n/m 10.26
P/S 8.25 77.54 9.18
P/B 1.53 1.91 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 4.48 49.93 8.98
Earnings yield (37.94%) (14.48%) (34.89%)
Free cash flow yield (26.87%) (12.78%) (24.52%)

Profitability

Metric COYA MNOV Biotechnology median
Gross margin 100.00% 37.76% 65.16%
Operating margin (288.70%) (1,287.53%) 0.00%
Net margin (270.22%) (1,168.31%) 0.00%
Free cash flow margin (221.64%) (991.31%) 0.00%
Return on equity (60.54%) (25.56%) (50.12%)
Return on assets (53.66%) (23.83%) (45.60%)
Return on invested capital (15,230.92%) (62.48%) 0.00%

Growth

Metric COYA MNOV Biotechnology median
Revenue growth (TTM) 108.35% (82.20%) 6.26%
EPS growth (last fiscal year) (29.59%) (4.35%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA MNOV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 8.75 4.89
Net debt to EBITDA 2.08 2.32 1.01

Dividend

Metric COYA MNOV Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COYA MNOV Biotechnology median
Market cap 65.92m 71.37m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack